The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-((1R,5aS,6R,9aS)-1,5a-dimethyl-7-methylene-3-oxo-6-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)ethenyl)decahydro-1H-benzo[c]azepin-1-yl)methyl pyrrolidine-2-carboxylate ID: ALA4580347
PubChem CID: 155565340
Max Phase: Preclinical
Molecular Formula: C25H34N2O5
Molecular Weight: 442.56
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=C1CC[C@H]2[C@@](C)(CCC(=O)N[C@@]2(C)COC(=O)[C@@H]2CCCN2)[C@@H]1/C=C/C1=CCOC1=O
Standard InChI: InChI=1S/C25H34N2O5/c1-16-6-9-20-24(2,18(16)8-7-17-11-14-31-22(17)29)12-10-21(28)27-25(20,3)15-32-23(30)19-5-4-13-26-19/h7-8,11,18-20,26H,1,4-6,9-10,12-15H2,2-3H3,(H,27,28)/b8-7+/t18-,19+,20+,24+,25+/m1/s1
Standard InChI Key: OLOTZDSWDWVPQN-ITAJTMSTSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
11.4283 -15.7743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8505 -15.1965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6390 -15.9858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1996 -15.0891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9049 -14.6847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9049 -13.8675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1996 -13.4548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4964 -13.8666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4943 -14.6847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8525 -13.3530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0499 -15.0199 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0501 -13.5370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6958 -14.2796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7048 -15.4730 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
8.8786 -14.2800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4902 -13.0462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1995 -12.6376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9071 -12.2288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9069 -11.4117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5644 -10.9284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3117 -10.1512 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4944 -10.1514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2422 -10.9286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3423 -11.1787 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6138 -13.4610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2455 -15.7743 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6541 -16.4820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4713 -16.4820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2455 -17.1897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9533 -17.1418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7305 -16.8893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7305 -16.0720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9533 -15.8196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 7 1 0
9 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
8 9 1 0
9 2 1 0
8 10 1 0
2 11 1 0
10 12 1 0
11 13 1 0
12 13 1 0
9 14 1 1
13 15 2 0
8 16 1 6
7 17 1 6
17 18 2 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 19 2 0
20 24 2 0
6 25 2 0
2 3 1 1
2 1 1 0
1 26 1 0
26 27 1 0
28 27 1 6
27 29 2 0
28 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 442.56Molecular Weight (Monoisotopic): 442.2468AlogP: 2.58#Rotatable Bonds: 5Polar Surface Area: 93.73Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.89CX Basic pKa: 7.45CX LogP: 2.24CX LogD: 1.91Aromatic Rings: ┄Heavy Atoms: 32QED Weighted: 0.50Np Likeness Score: 2.31
References 1. Wang W, Wu Y, Yang K, Wu C, Tang R, Li H, Chen L.. (2019) Synthesis of novel andrographolide beckmann rearrangement derivatives and evaluation of their HK2-related anti-inflammatory activities., 173 [PMID:31009914 ] [10.1016/j.ejmech.2019.04.022 ]